Now in its fourth year, the Western Atrial Fibrillation Symposium hosted over 350 cardiologists, physicians and others at this world-class conference demonstrating the latest research and clinical developments in diagnosing, treating and managing AF. It is particularly exciting to see how close we are to introducing some of these game-changing advances, including real-time MRI catheter guidance, into clinical practice.
The Symposium, which was sponsored by the University of Utah School of Medicine’s Division of Cardiology and co-sponsored by The Heart Rhythm Society (HRS), had many fantastic presentations from the world’s leading experts. For example, Dr. David Wilber from Loyola University provided conference attendees with the latest updates on the large AF clinical studies in progress, including CASTLE-AF and DECAAF, as well as an overview of recently completed randomized trials. Other highlights from the symposium’s distinguished international faculty included:
Opinions expressed by authors, contributors, and advertisers are their own and not necessarily those of HMP Communications, the editorial staff, or any member of the editorial advisory board. HMP Communications is not responsible for accuracy of dosages given in articles printed herein. The appearance of advertisements in this journal is not a warranty, endorsement or approval of the products or services advertised or of their effectiveness, quality or safety. HMP Communications disclaims responsibility for any injury to persons or property resulting from any ideas or products referred to in the articles or advertisements.